Marshall Wace’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,012,642
| Closed | -$10.2M | – | 3217 |
|
|
2022
Q4 | $10.2M | Hold |
1,012,642
| – | – | 0.02% | 685 |
|
|
2022
Q3 | $10.1M | Buy |
1,012,642
+95,700
| +10% | +$950K | 0.02% | 782 |
|
|
2022
Q2 | $9.08M | Hold |
916,942
| – | – | 0.02% | 863 |
|
|
2022
Q1 | $9.03M | Hold |
916,942
| – | – | 0.02% | 888 |
|
|
2021
Q4 | $9.02M | Buy |
916,942
+600,918
| +190% | +$5.91M | 0.02% | 865 |
|
|
2021
Q3 | $3.08M | Buy |
316,024
+216,038
| +216% | +$2.1M | 0.01% | 1029 |
|
|
2021
Q2 | $967K | Hold |
99,986
| – | – | ﹤0.01% | 1415 |
|
|
2021
Q1 | $970K | Buy |
+99,986
| New | +$970K | ﹤0.01% | 1414 |
|